Abstract
Neurodegenerative disorders (NDs) are a heterogeneous group of disorders generally characterized by a profound decrease in the size and volume of the human brain due to death of neurons. These disorders include a variety of progressive disorders that result in cognitive and/or motor degradation. The present study was conducted to identify common potential targets for multi-neurodegenerative diseases. To accomplish this, we have selected six common neurodegenerative diseases, Alzheimer’s disease (AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), Prion disease and Dentatorubral-pallidoluysian atrophy (DRPLA) for identification of common regulatory target proteins. A total of sixteen common proteins were identified as target proteins by disease pathway analysis and previous studies based on their association with more than two NDs, including AD. An interaction network of each of the sixteen target proteins was then constructed against causative proteins selected from all six NDs by using the STRING 9.1 program. Pathway analysis and the protein–protein interaction network suggested that CASP-3 and CASP-8 were associated with the maximum number of selected NDs and may therefore be the most potent target proteins for treatment of multi-neurodegenerative diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
